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Abstract
Background:  Abdominal and retroperitoneal Castleman's disease could present either as a
localized disease or as a systemic disease. Castleman's disease is a lymphoid hyperplasia related to
human Herpes virus type 8, which could have an aggressive behavior, similar to that of malignant
lymphoid neoplasm mainly with the systemic type, or a benign one in its localized form.
Methods: The authors report two cases of localized Castleman's disease in the retroperitoneal
space and review the current and recent progress in the knowledge of this atypical disease.
Cases presentation: The two patients were young healthy women presenting with a hyper
vascular peri-renal mass suggestive of malignant tumor. Both have been resected in-toto. One of
them had an extensive resection with nephrectomy, while the second had a kidney preserving
surgery. Pathological examination revealed localized Castleman's disease and surgical margins were
free of disease. Postoperative course was uneventful, and after more than 5-years of follow-up no
recurrences have been observed.
Conclusion:  Localized Castleman's disease should be considered when facing a solid
hypervascular abdominal or retroperitoneal mass. A better knowledge of this disorder and its
characteristic would help surgeon to avoid unnecessarily extensive resection for this benign
disorder when dealing with abdominal or retroperitoneal tumors. Surgical resection is curative for
the localized form, when complete, while splenectomy could be indicated for the systemic form.
Background
Castleman's disease (CD) is a rare lymphoid disorder where
pathogenesis is a lymphoid tissue hyperplasia related to
chronic herpes virus infection. It has been described in
nearly every lymph node basin since it first description by
B. Castleman in 1956 [1,2]. Two basic pathologic types of
this disease could be encountered: the hyaline vascular
(HV) and the plasma cell (PC) types. The first tends to be
localized in one lymph node and asymptomatic; the sec-
ond has a more aggressive course and tends to be multifo-
cal with systemic manifestations.
The authors' present two cases of localized Castleman's
disease arising in the peri-renal space and review previous
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reports abdominal and retroperitoneal CD. A review of lit-
erature on Castleman's disease pathogenesis, clinical and
radiological characteristics as well as its treatment is also
included in this manuscript.
Case presentation
Case 1
A 33-years-old woman with no significant past medical
history complained of abdominal right upper quadrant
discomfort associated with an history of weight lost (8 kg
over 2 months). Physical examination revealed a right
upper quadrant mass on deep palpation. Routine hema-
tology and blood biochemistry were normal. The patient
was HIV1-2 negative. Chest and abdominal roentgeno-
grams were considered normal. Abdominal ultrasonogra-
phy (USG) revealed a large hypoechogenic mass, with
regular border in the right anterior peri-renal space. Com-
puted tomography (CT) scan showed a 10 × 8 cm mass
with regular contour, containing small calcifications,
which strongly enhanced with vascular contrast. The
lesion was in contact with the right kidney and ureter. Sur-
gery was planned with a preoperative diagnosis of malig-
nant retroperitoneal tumor versus lymph node
hyperplasia.
Through a right transverse incision, after mobilization of
the duodeno-pancreatic bloc, a tumor was found in con-
tact of the right kidney, ureter and caval vein. While the
possibility of malignancy could not be neglected, the
mass was dissected en-bloc with wide margin in peri-renal
fat. To allow free surgical margin clinically a segment of
the right ureter as well as inferior pole of kidney were also
excised en bloc. A right nephrectomy was finally performed
latter on as the ureteral defect could not be repaired.
Histopathological examination of resected specimen
revealed localized Castleman's disease of the hyaline vas-
cular type. Patient had smooth postoperative recovery and
is free of disease more than 6 years after resection.
Case 2
A 25-year-old woman with no significant past medical
history, presented with post-prandial epigastric discom-
fort evolving over 2 years and post-prandial vomiting
since 1 month. The patient reported 2.5 kg weight loss
over 2 months. Physical examination revealed a left para-
renal mass on deep palpation. Blood analyses were not
relevant. CEA and CA19-9 were in the normal range. The
patient was HIV1-2 negative. Chest and abdominal X-ray
films were considered normal. An upper abdominal bar-
ium follow through was considered normal. Abdominal
ultrasonography revealed a 6 cm diameter hypoechogenic
mass in the left peri-renal space. CT scan showed a 6 × 7
cm mass, containing multiple small calcifications, which
was highly hypervascular and regular in shape (figure 1).
An arteriography confirmed the presence of hypervascu-
larity with flushing of the mass (figure 2). Surgery was
planned with a preoperative diagnosis of malignant retro-
peritoneal tumor.
At laparotomy a 7 cm diameter mass was found in the left
anterior peri-renal space, just inferior to the renal artery.
The lesion was completely excised with what seems, clini-
cally, to be a capsule. No organ resection was needed.
Pathologic diagnosis was localized Castleman's disease of
the hyaline vascular type. Patient had had a simple post-
operative period, except of persisting lumbar pain, attrib-
uted to a small inferior renal infarct (confirmed by CT
scan). The patient is free of disease 5-years after resection.
Discussion
Castleman's disease (CD), also known as angiofollicular
lymph node hyperplasia, was first reported by Symmers in
1921 [3]. This pathology was characterized by B. Castle-
man in 1956 as a benign lymph node hyperplasia resem-
bling a thymoma [1,2]. Keller et al identified two
pathologic types of CD in 1972 [4]. First the hyaline vas-
cular (HV) type which present as a pathological and exten-
sively hypertrophied lymph node. Macroscopically it
appears as an encapsulated homogenous mass with an
orange-yellowish color. Microscopically, it is character-
ized by giant lymph follicles centered on a central vessel
with marked hyalinization. Follicles are surrounded by
circumferentially arranged layer, in an onion skin feature,
of small polyclonal B-lymphocytes. These pathologic
lymph nodes present a strong hypertrophied vascular
arborescence [4-8]. The plasma cell (PC) type has the
same macroscopic aspect as HV type, but contains much
more mature polyclonal plasma cells with a less marked
hyalinization and vascularization [4,6-8]. It been shown
that this two types histology are not always clearly sepa-
rated and that mixed HV-PC types can also occur [7]. The
histology of PC type is not specific of systemic CD and can
be found in autoimmune disease, AIDS and in lymph
nodes draining carcinoma, so it is imperious to exclude
this condition before diagnosing CD of PC type [5,6]. This
implies that serologic testing for HIV should be performed
whenever a diagnosis of CD is contemplated[5,6].
The etiology of CD is related to chronic Human Herpes
virus 8 (HSV8) [7] as HSV8 has been found in lymphoid
cells in case of systemic form, or PC type, of Castleman's
disease [9]. Its nature is not neoplastic as confirm by the
fact that the lesion are made of a polyclonal proliferation
[6,7]. It's seems that CD is the result of a chronic low grade
inflammatory process triggered by latent infection with
HSV8, which leads to lymphoid system hyperplasia [5-7].
Human herpes virus 8 (HSV8), also called Kaposi's sar-
coma-associated herpes virus (KHSV) is the initiator ofWorld Journal of Surgical Oncology 2005, 3:33 http://www.wjso.com/content/3/1/33
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this chronic inflammation by establishing a chronic or
latent infection in lymph nodes [7]. Chronic infection by
HSV8 stimulates secretion of IL-6 which in turn induces a
hyperplasic reaction of the lymphoid system [6,7]. While
this lymphoid hyperplasia could be contained in one
lymph node as in the localized form, which is mainly of
HV type, it could also be generalized as in the systemic, or
multifocal, form which is the predominant form for the
PC type [6]. The patient's immunological status seems to
play a major role in the development of these two forms.
While localized form is encountered mainly in immuno-
competent patients, the systemic form is found in patient
with AIDS or other immunodeppression related either to
immunosuppression or pathological state [6].
The localized form of CD arises predominantly in the
mediastinum, where it was first described by B. Castleman
[1]. However, it can be found in the neck, abdomen,
axilla, inguinal region and in virtually all lymph node area
[5,7,8,10,11]. Even non-nodal tissue could be involved, as
is has been described in: lung, pancreas, breast, adrenal
gland, muscle and other extremely rare locations
[4,7,10,11]. Testa et al [11] have reported the location of
315 cases of localized CD, 65% were in the mediastinum,
16% in the neck, 12% in the abdomen, 3% in the axilla
and 4% in diverse locations.
Computed tomography scanner showing a large left-pararenal mass (Hyalin-vascular type of Castleman's disease) Figure 1
Computed tomography scanner showing a large left-pararenal mass (Hyalin-vascular type of Castleman's disease). Note the 
presence of microcalcification (white spot) within the mass.World Journal of Surgical Oncology 2005, 3:33 http://www.wjso.com/content/3/1/33
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A literature review of the abdominal and retroperitoneal
case of localized HV type of CD has been done. In 1992,
54 abdominal and retroperitoneal cases were reviewed by
Seco et al [5]. Now 195 cases of localized CD have been
reported, in the world literature, arising in the abdomen
and retroperitoneum. Of these 195 cases, 122 (63%) were
in the retroperitoneum and 73 (37%) in the abdominal
cavity (Table 1). Of the 122 lesions localized in the
Arteriography showing the presence of a hypervascular mass (Hyalin-vascular type of Castleman's disease) with rapid flushing  of the tumor Figure 2
Arteriography showing the presence of a hypervascular mass (Hyalin-vascular type of Castleman's disease) with rapid flushing 
of the tumor. The feeding vessels originated from the aorta and left renal artery.World Journal of Surgical Oncology 2005, 3:33 http://www.wjso.com/content/3/1/33
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retroperitoneum, 24 (20%) were in the peri-renal region,
as were our cases. Nearly all this lesions were derived from
lymph node tissue, but 5 of these 195 cases (2%) seem to
have originating in extra lymphoid organ. Three pancre-
atic, and one each of splenic and adrenal CD have been
described [58-60,65,80].
The clinical presentations of CD differ greatly between the
localized and the systemic forms (Table 2). The first
appears in young generally healthy patients and cause few
symptoms [6,7]. Abdominal and retroperitoneal loca-
tions, as were our cases, can be associated with mass effect
symptoms related to compression of adjacent organs. This
could present as: post-prandial discomfort, anorexia,
vomiting, weight loss, urinary retention and abdominal
or lumbar pain [80]. Systemic, or multifocal, CD is asso-
ciated with systemic disturbance as anemia, increased
erythrocyte sedimentation rate, polyclonal hypergamma-
globulinemia, hypoalbuminemia and thrombocytopenia
which all can be associated with a specific symptoms [6-
8]. The clinical picture includes asthenia, fever, weight
loss, generalized lymphadenopathy, hepatomegaly,
splenomegaly, peripheric edema, pleural effusion,
impaired renal function and sometimes polyneuropathy
[6-8]. Rarely POEMS syndrome (Polyneuropathy, Orga-
nomegaly, Endocrinopathy, M protein and Skin change)
or amyloidosis may be associated to systemic CD [6-8].
Table 1: Abdominal and retroperitoneal case of localized Castleman's disease (HV type)
Location Number of cases Authors
Retroperitoneum9 7S e c o   et al [5], Bapat et al [12], Yamakita et al [13], Morishita et al [14], Genoni et al [15], Ng et al [16], 
Baikovas et al [17], Johnson et al [18], Martino et al [19], Guglielmi et al [20], Ziv et al [21], Gheysens et 
al [9], Halvic et al [22], Herrada et al [23], Furuhata et al [24], Ebine et al [25], Sadamoto et al [26], 
Gravalos et al. [27], Iwamoto et al [28], Sanna et al [29], Singletary et al [30], Curciacrello et al [31], 
Gonzalez Sanchez et al [32], Schutz et al [33], Perez Garcia et al [34], Irsutti et al [35], Parez et al [36], 
Buchanan et al [37]
Peri-renal 24 Ebisno et al. [38], Inoue et al. [39], Takihara et al. [40],,Feudis et al [41], Barret et al. [42], Okada et al 
[43], Present two cases
Mesentery 27 Seco et al. [5], Barki et al. [44], Hung et al. [45], Schroff et al. [46], Makipernaa et al. [47], De Heer-
Groen et al [48], Parez et al [36], Neerhout et al [49], Powel et al [50], Burke et al [51]
Greater omentum 3 Volta et al [52], Kiguchi et al [53]
Gastric 2 Kiguchi et al [53], Yebra et al [54]
Peri-pancreatic 5 Kiguchi et al [53], Rotman et al [55], Brossard et al [56], Inoue et al [39], Erkan et al [57]
Pancreatic 3 Chaulin et al [58], Corbisier et al [59], Lepke et al [60]
Porta hepatitis 5 Rahmouni et al [61], Farkas et al [62], Peck et al [63], Cirillo et al [64]
Adrenal gland 1 Debatin et al [65]
Pelvis 27 Seco et al [5], Latte et al [66], Daley et al [67], Boxer et al. [68], Tsukamoto et al [69], Luburich et al [70], 
Isik et al [71], Ylinen et al [72], Schwartz et al [73], Mondal et al [74], Kiguchi et al [53], Calvo Villas et al 
[75], Mac Donald et al [76], Fields et al [77], Kkasantikul et al [78], Halvic et al [22], Murphy et al [79]
Spleen 1 Taura et al [80]
Total of cases 195
Table 2: Clinical forms of Castleman's disease
Localized form Multifocal form
Mean age (years) 3rd decade 6th decade
Clinical signs Incidental mass effect Systemic symptoms
Localization Mediastinum, cervical or abdominal, etc... Multifocal, mostly peripheric lymph nodes
Histologic type HV, rarely HV-PC PC
Treatment Surgical resection Corticosteroids, chimiotherapy, radiotherapy
Prognosis Excellent: 100% survival at 5 years Poor: median survival of 30 months
Recurrence after treatment Extremely rare, related to incomplete resection Nearly always
Association Rarely lymphoma Frequent: AIDS, Kaposi's sarcoma, lymphoma and myeloma
Table adapted according to references: [5, 6, 7, 11]World Journal of Surgical Oncology 2005, 3:33 http://www.wjso.com/content/3/1/33
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Radiographic characteristics of CD are non specific, but
some features could help to suspect the diagnosis (Table
3) [77,80]. Plain radiographic finding includes a mass
effect and in nearly 30% of localized form calcifications
harboring a radial arrangement or star-shaped calcifica-
tions which is said to be characteristic of CD [77]. Ultra-
sonography (US) usually demonstrates a hypoechogenic
and homogenous mass with quite clear delimitation
[8,30,77]. US can show central areas of sharp acoustic
shadowing due to calcification [30]. CT scan show a solid,
homogenous and well delimited mass which enhance
with vascular contrast as a results of hypervascularity
[5,30,77,80]. It can also show star-shaped microcalcifica-
tions which are quite specific on pre-contrast images
[5,27,77]. Post-contrast IV study, while demonstrating
dense enhancement of the mass, could demonstrate a cen-
tral stellate scar [30,80]. Angiography shows a strongly
hypervascular lesion, which present a dense and homoge-
nous flush during the capillary phase [5,6,8,40,53,77,80].
This flush begins in periphery to become diffuse whiting
the mass and is specific for the HV type of CD [77,80]. It
can also demonstrate hypertrophied feeding vessel, an
useful information when resection is plan [8,53,77,80].
Magnetic resonance imaging (MRI) characteristics of CD
are: hypodense mass on the T1 weighted study and hyper-
dense lesion on the T2 weighted image sometimes with
star-shaped calcifications [60,77,80]. Gadolinium injec-
tion produces an enhancement which appear in periphery
to become diffuse similarly to the flush observed during
angiography [77,80]. All these radiological finding are not
specific but some like the star-shaped calcifications and
the type of hypervascularisation are quite specific and
should alert clinician to the possibility of CD. In sum-
mary, in front of an abdominal or retroperitoneal mass
which is well delimited, homogenous and harbor star-
shaped calcifications and hypervascularisation associated
with typical flush, the diagnosis of CD should be strongly
suspected [53,77,80]. The differential radiological diagno-
sis is mainly malignant neoplasm because of the hyper-
vascularity [40,77], and the fact that 80% of the
retroperitoneal tumor are malignant [40,81,82]. The
major tumors found in the retroperitoneum are soft tissue
sarcoma (liposarcoma, fibrosarcoma, leiomyosarcoma,
neurofibrosarcoma, undifferentiated and rabdomyosar-
coma) which are frequently heterogeneous mass and
show necrosis on CT scanner; vascular tumor (hemangi-
osarcoma and lymphangiosarcoma) which are cystic and
of liquid density on USG and CT scanner; and the lym-
phoma which generally presents as multiple adenopathy
and homogeneous mass on CT scanner [30,83-86]. Uro-
logical tumors like seminoma, prostatic cancer and ter-
atoma tends to give rise to metastatic disease in the
retroperitoneum in the form of adenopathy which are
generally multiple [86]. While a preoperative diagnosis of
CD is difficult to obtain, fine needle biopsy is not a defin-
itive tools because of there low specificity and the differ-
ential diagnosis with lymphoma is impossible by this
approach [77,88]. In addition to be non-specific and
rarely yielding enough useful tissue, needle biopsy is asso-
ciated with tumoral seeding with reported frequency of 1/
40 000 to 1/1 000 biopsy [83,89]. Thus when surgery is
planned, indication for fine needle biopsy should be care-
fully deliberated, while an open biopsy could always be
done during surgery [83].
Treatment of CD differs between localized and multifocal,
or systemic, forms. The standard therapy of localized form
is surgical excision which is curative when resection is
complete and en-bloc. No recurrences have been reported
after total excision in the literature as it was the case with
our cases [5-7,11,38,40,53,82,90]. Because these lesions
are highly vascularised, embolization before surgery
could be helpful to minimize blood lost during surgery
[5,53]. The problem that is faced during resection is to
resolve the differential diagnose between a malignant
pathology and CD. Macroscopically it is nearly impossi-
ble because CD lesions harbor dense fibrous adherences
to adjacent organ and hypervascularization typically seen
in malignant pathology [5,38,82,90]. For this reason per-
operative diagnosis by open biopsy is helpful, and
Table 3: Radiological characteristics of Castleman's disease
Non specific signs Specific signs
Radiography calcification. Star-shaped calcification.
Echography Hypoechogenic and homogenous mass. Central areas of acoustic 
shadowing (calcification).
CT scanner Tissue density, Homogenous and well delimited mass. Contrast 
enhancement beginning in periphery.
Star-shaped microcalcifications Star-shaped scar on post-
contrast study.
Arteriography Hypervascularity with hypertrophied feeding vessel. Flush beginning in periphery to become diffuse and 
homogenous during capillary phase.
MRI Hypodense on T1 and hyperdense on T2. Contrast enhancement 
beginning in periphery.
Star-shaped microcalcification or star-shaped hypodense 
signal on T2.
Table adapted according to references: [5,9,27,30,34,42,48,65,]World Journal of Surgical Oncology 2005, 3:33 http://www.wjso.com/content/3/1/33
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necessary in case of CD suspicion. It enables one to avoid
extensive resection and especially resection of nearby
organ for this benign disorder which does not invade
adjacent organ even in case of tight contact [38,82,83,90].
The five years survival after resection is nearly 100% for
the localized form [6]. Recurrences have rarely been
reported generally when excision was incomplete
[6,38,82,90]. For the systemic form no curative therapies
have been found yet. Corticotherapy, immunosuppressive
drugs, chemotherapy and radiotherapy have been tried
without any convincing results [5-7,91,92]. The prognosis
of this form is poor with a median survival of 30 months
[6]. However recently, the reports of improvement and
prolonged survival after splenectomy have been reported
with steroid therapy and chemotherapy this could change
the prognosis of the systemic form in the future [91,92].
Of importance from the surgical point of view is that in
these cases the remission was obtained after splenectomy
only [91]. The systemic, PC type, and extremely rarely the
localized, HV type, forms are associated with malignant
disorder such as Kaposi's sarcoma, malignant lymphoma
and myeloma. This association is stronger in HIV positive
patients with CD, for example Kaposi's sarcoma is associ-
ated to 13% of case of PC type CD in HIV negative and in
75% of case when HIV positive patients. The association
with Kaposi's sarcoma could be explained by the fact that
HSV8 is cause in the pathogenesis of these two disorders
[7]. These neoplasms can appear as late as 8 years after the
diagnosis of CD, so a long term follow-up is required in
patient in whom the diagnosis of CD has been established
[6].
Conclusion
Castleman's disease (CD) is a rare lymphoid disorder,
where etiology is related to Human herpes virus 8. CD
could present in two forms: the localized (hyaline vascu-
lar type) and the systemic (plasma cell type). The localized
hyaline vascular form has a unique indolent lymph node
hyperplasia; which can be found in the abdomen, retro-
peritoneum or any lymph node basin; as a solitary mass.
Localized CD is radiologically nearly undistinguishable
from malignant neoplasms but some characteristics are
quite specific, like the type of hypervascularization and
the star-shape microcalcifications. A good preoperative
work-up and an open biopsy during surgery, for abdomi-
nal and retroperitoneal mass if no diagnosis has been
establish, can help to avoid extensive resection when fac-
ing this benign disorder. Complete surgical excision is
curative; recurrences have only been described after
incomplete resection. The prognosis is excellent with a
five years survival of nearly 100%.
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